Item 7.01 Regulation FD Disclosure.

On March 29, 2022, Pardes Biosciences, Inc. (the "Company") announced its financial results for the year ended December 31, 2021. The full text of the press release issued in connection with the announcement is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

The information in this Item 2.02, including the attached Exhibit 99.1, is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing made by the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.



Item 9.01 Exhibits.

(d) Exhibits

Exhibit No.                                   Description
99.1            Press Release by the Company dated March 29, 2022.
104           Cover Page Interactive Data File (embedded within the Inline XBRL document).



                                       1

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses